Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. World Health Organization. Investing to overcome the global impact of neglected tropical diseases. Third WHO report on neglected tropical diseases. WHO/HTM/NTD/2015.1 (2015).
2. Sundar, S. & Singh, A. Recent developments and future prospects in the treatment of visceral leishmaniasis. Ther. Adv. Infect. Dis. 3, 98–109, doi:
10.1177/2049936116646063
(2016).
3. Gutierrez, V., Seabra, A. B., Reguera, R. M., Khandare, J. & Calderon, M. New approaches from nanomedicine for treating leishmaniasis. Chem. Soc. Rev. 45, 152–168, doi:
10.1039/c5cs00674k
(2016).
4. Garami, A. & Ilg, T. Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability. EMBO J 20, 3657–3666, doi:
10.1093/emboj/20.14.3657
(2001).
5. Stewart, J. et al. Characterization of Leishmania mexicana knockout lacking guanosine diphosphate-mannose pyrophosphorylase. Int. J. Parasitol. 35, 861–873, doi:
10.1016/j.ijpara.2005.03.008
(2005).
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献